Search filters

List of works by Francesco Patti

A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients

scientific article published on 21 January 2020

Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study

scientific article published on 05 March 2020

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes

scientific article published on 13 October 2016

Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy

scientific article published on 20 June 2019

An update on the pharmacological management of pain in patients with multiple sclerosis

scientific article published on 28 April 2020

Box and Block Test, Hand Grip Strength, and 9-Hole Peg Test: Correlations between Three Upper Limb Objective Measures in Multiple Sclerosis

scientific article published on 03 July 2020

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

scientific article published on 08 August 2019

Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab

scientific article published on 27 March 2020

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

scientific article

Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)

scientific article published on 13 April 2020

Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis

scientific article published on 14 October 2020

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

scientific article published on 26 December 2017

Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

scientific article published on 04 December 2018

EAN guideline on palliative care of people with severe, progressive multiple sclerosis

scientific article published on 29 May 2020

Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience

scientific article published on 03 October 2018

Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study

scientific article published on 25 April 2020

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

scientific article published on 23 October 2017

Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study

scientific article published on 17 June 2020

Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study

scientific article published on 22 April 2020

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

scientific article

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

article

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

scientific article published on 11 September 2015

Genetic burden of common variants in progressive and bout-onset multiple sclerosis

scientific article published on 28 November 2013

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

scientific article published on 29 December 2013

Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study

scientific article

Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers

scientific article published on 29 July 2015

Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support

scientific article published on 06 May 2019

Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study

scientific article published on 03 August 2018

Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis ⬇️

scientific article published on March 15, 2011

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

scientific article published on 10 June 2020

Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.

scientific article published on 22 April 2009

Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

scientific article

Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

scientific article

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study

scientific article published on 13 July 2020

Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up

scientific article published on 12 September 2014

Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study

scientific article published on 03 December 2020

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

scientific article

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis

scientific article published on 09 September 2018

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs

scientific article published on 8 January 2014

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

scientific article

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

scientific article published on 7 February 2018

Prognostic indicators in pediatric clinically isolated syndrome

scientific article published on 25 April 2017

Reply to Comment on "Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study"

scientific article published on 07 September 2020

Rituximab for the treatment of multiple sclerosis: a review

scientific article published on 08 January 2021

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

scientific article

Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosis

scientific article published on 23 December 2017

Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager® evaluation study

scientific article published on 08 September 2018

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

scientific article

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.

scientific article

The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.

scientific article

The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis

scientific article published on 11 February 2016

The heritage of glatiramer acetate and its use in multiple sclerosis

article by Giancarlo Comi et al published 4 July 2016 in Multiple Sclerosis and Demyelinating Disorders

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

scientific article published on 19 November 2020

Treatment of cognitive impairment in patients with multiple sclerosis ⬇️

scientific article published on August 9, 2012

Paulina is supported by:

About Paulina

Help